These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 28115927)

  • 21. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
    Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
    Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR; Xu XJ; Yao SK
    World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of psychological stress on irritable bowel syndrome.
    Qin HY; Cheng CW; Tang XD; Bian ZX
    World J Gastroenterol; 2014 Oct; 20(39):14126-31. PubMed ID: 25339801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T
    Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of inflammation in irritable bowel syndrome (IBS).
    Ng QX; Soh AYS; Loke W; Lim DY; Yeo WS
    J Inflamm Res; 2018; 11():345-349. PubMed ID: 30288077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.
    González-Castro AM; Martínez C; Salvo-Romero E; Fortea M; Pardo-Camacho C; Pérez-Berezo T; Alonso-Cotoner C; Santos J; Vicario M
    J Gastroenterol Hepatol; 2017 Jan; 32(1):53-63. PubMed ID: 27087165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irritable bowel syndrome: a gut microbiota-related disorder?
    Bhattarai Y; Muniz Pedrogo DA; Kashyap PC
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G52-G62. PubMed ID: 27881403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Stress-mast cell axis and regulation of gut mucosal inflammation: from intestinal health to an irritable bowel].
    Ramos L; Vicario M; Santos J
    Med Clin (Barc); 2007 Jun; 129(2):61-9. PubMed ID: 17588364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.
    Vicario M; Guilarte M; Alonso C; Yang P; Martínez C; Ramos L; Lobo B; González A; Guilà M; Pigrau M; Saperas E; Azpiroz F; Santos J
    Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review.
    Tang HY; Jiang AJ; Wang XY; Wang H; Guan YY; Li F; Shen GM
    Ann Transl Med; 2021 Jul; 9(14):1187. PubMed ID: 34430628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irritable bowel syndrome and food interaction.
    Cuomo R; Andreozzi P; Zito FP; Passananti V; De Carlo G; Sarnelli G
    World J Gastroenterol; 2014 Jul; 20(27):8837-45. PubMed ID: 25083057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costunolide ameliorates intestinal dysfunction and depressive behaviour in mice with stress-induced irritable bowel syndrome
    Li X; Liu Q; Yu J; Zhang R; Sun T; Jiang W; Hu N; Yang P; Luo L; Ren J; Wang Q; Wang Y; Yang Q
    Food Funct; 2021 May; 12(9):4142-4151. PubMed ID: 33977961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome.
    Lee H; Park JH; Park DI; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Chae SW
    J Neurogastroenterol Motil; 2013 Apr; 19(2):244-50. PubMed ID: 23667756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of mast cells in functional GI disorders.
    Wouters MM; Vicario M; Santos J
    Gut; 2016 Jan; 65(1):155-68. PubMed ID: 26194403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.
    Ringel Y; Maharshak N
    Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(8):G529-41. PubMed ID: 23886861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.
    Camilleri M; Lasch K; Zhou W
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G775-85. PubMed ID: 22837345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome.
    Chen M; Ruan G; Chen L; Ying S; Li G; Xu F; Xiao Z; Tian Y; Lv L; Ping Y; Cheng Y; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():817100. PubMed ID: 35250873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.